Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Genetics

Background:

• Pulmonary arterial hypertension (PAH) is a severe, chronic vascular disease with limited treatment options.
• Micro-RNAs (miRNAs) play a crucial role in the multifactorial pathogenesis of PAH through gene expression regulation.
• The rapidly evolving field of miRNA research in PAH presents challenges in identifying therapeutically relevant targets.

Purpose of the Study:

• To review current knowledge on miRNA expression profiles in pulmonary arterial hypertension.
• To discuss the analytical and interpretative challenges in studying miRNAs in PAH.
• To identify and highlight specific miRNAs with high translational potential for PAH therapeutics.

Main Methods:

• Comprehensive literature review of studies investigating miRNA expression in PAH.
• Analysis of existing data on miRNA deregulation in pulmonary arterial hypertension.
• Identification of miRNAs consistently implicated in PAH pathogenesis and progression.

Main Results:

• miRNA expression is significantly altered in patients with pulmonary arterial hypertension.
• Specific miRNAs, including miR-29, miR-124, miR-140, and miR-204, show promise due to their roles in PAH.
• Challenges in miRNA detection and functional validation impact translational efforts.

Conclusions:

• miRNA deregulation is a key feature of pulmonary arterial hypertension pathogenesis.
• miR-29, miR-124, miR-140, and miR-204 represent promising therapeutic targets for PAH.
• Further research is needed to overcome analytical hurdles and advance miRNA-based PAH treatments.